TP53 and small cell lung carcinoma: Based on prior studies, it is known that SCLC can rarely arise in never or light smokers via histologic transformation of lung adenocarcinoma (LUAD) either after treatment with targeted therapies or de novo (7, 8), and that RB1 and TP53 co-deficiency is a prerequisite for this conversion (9, 10).